Finance

Beta
Lists
ROSSARI:NSE
Rossari Biotech Ltd
₹524.00
-0.51%
(-2.70) 1D
Jun 5, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ROSSARI...
Open
₹530.00
High
₹531.95
Low
₹521.00
Mkt. cap
29.19B
Avg. vol.
321.14K
Volume
53.50K
P/E ratio
19.46
52-wk high
₹766.00
52-wk low
₹375.00
EPS
₹26.93
No. of employees
535
Open
₹530.00
High
₹531.95
Low
₹521.00
Mkt. cap
29.19B
Avg. vol.
321.14K
Volume
53.50K
P/E ratio
19.46
52-wk high
₹766.00
52-wk low
₹375.00
EPS
₹26.93
No. of employees
535
News stories
From sources across the web
Profile
Rossari Biotech is an Indian chemical manufacturing company with a focus on specialty chemicals. It is also engaged in production of specialty enzymes and chemicals in India that is used in the pharmaceuticals, paper, construction, textiles, nutrition and animal health industries. The company was started in 2003 as a partnership firm titled Rossari Labtech and was incorporated into a company in 2009 and was renamed as Rossari Biotech. It has two R&D facilities, one at Silvassa manufacturing facility and the second in Dahej. Wikipedia
About Rossari Biotech Ltd
CEO-
Employees535
FoundedAug 10, 2009
Headquarters-
SectorSpeciality chemicals
Last report
Apr 28, 2026
Fiscal period
Q4 2026
EPS / Est. (INR)
₹8.29 / ₹6.30
+31.59%beat
Revenue / Est. (INR)
6.85B / 6.10B
+12.35%beat
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
5.44B
5.86B
5.82B
6.85B
Cost of goods sold
3.71B
4.01B
4.01B
4.96B
Cost of revenue
3.71B
4.01B
4.01B
4.96B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
374.65M
377.99M
402.56M
392.28M
Operating expense
1.22B
1.32B
1.32B
1.35B
Total operating expenses
4.94B
5.32B
5.32B
6.31B
Operating income
501.06M
536.91M
492.59M
537.23M
Other non operating income
12.00M
16.04M
5.09M
190.65M
EBT including unusual items
460.99M
496.72M
425.01M
642.43M
EBT excluding unusual items
460.99M
496.72M
425.01M
642.43M
Income tax expense
125.03M
127.96M
97.27M
182.76M
Effective tax rate
27.12%
25.76%
22.89%
28.45%
Other operating expenses
670.48M
755.29M
717.50M
726.60M
Net income
335.96M
368.76M
327.74M
459.67M
Net profit margin
6.18%
6.29%
5.63%
6.71%
Earnings per share
6.06
6.65
5.91
8.29
Interest and investment income
-
-
-
-
Interest expense
-57.28M
-60.91M
-76.65M
-90.59M
Net interest expenses
-57.28M
-60.91M
-76.65M
-90.59M
Depreciation and amortization charges
177.49M
182.33M
196.14M
235.28M
EBITDA
654.45M
716.82M
645.98M
735.04M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more